BATS BZX Real-Time Price
As of 10:12am ET
| +0.29 / +2.52%|
The 8 analysts offering 12-month price forecasts for Sucampo Pharmaceuticals Inc have a median target of 16.50, with a high estimate of 29.00 and a low estimate of 13.00. The median estimate represents a +40.07% increase from the last price of 11.78.
The current consensus among 8 polled investment analysts is to Buy stock in Sucampo Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.